Tag: MIRV therapy

#VisualAbstract: Mirvetuximab soravtansine-gynx compared to chemotherapy in folate receptor alpha-positive platinum resistant ovarian cancer led to improved survival

byMinjee Kim

December 28, 2023

1. Mirvetuximab soravtansine-gynx (MIRV) significantly improved progression-free survival, objective response, and overall survival compared to chemotherapy in patients with platinum-resistant, ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Delayed initiation of antibiotic therapy is associated with worse outcomes in skin and soft tissue infections
Caloric restriction and intermittent fasting show mixed human longevity data
Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

No Result

View All Result